drugset / Trial / NCT01435122
A Study of Axitinib in Advanced Carcinoid Tumors
Phase 2
Completed
30 enrolled
H. Lee Moffitt Cancer Center and Research Institute
National Comprehensive Cancer Network · collabPfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to see whether Axitinib will help prolong the time that the patient's carcinoid tumors remain stable, and to examine their treatment response through testing. Researchers also want to find out if Axitinib is safe and tolerable.
Timeline
- Start
- 2011-10-25
- Primary completion
- 2017-01-11
- Completion
- 2018-02-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | — | Oral |